# Streamex Corp.: financial statements, quarterly

STEX · Nasdaq · CIK 1530766 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stex.md) · [Financials](/companies/stex/financials.md) · [Filings](/companies/stex/filings.md) · [Insiders](/companies/stex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001493152-24-045687.md) | [0.0 d](/filings/0001641172-25-004816.md) | [0.0](/filings/0001641172-25-011419.md) | [0.0](/filings/0001641172-25-024455.md) | [0.0 d](/filings/0001493152-25-023661.md) | [0.0 d](/filings/0001493152-26-014376.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-038293.md) | [0.1](/filings/0001493152-26-038293.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [0.0](/filings/0001493152-23-041256.md) | [0.0 d](/filings/0001493152-24-014860.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [1.1](/filings/0001493152-24-045687.md) | [1.2 d](/filings/0001641172-25-004816.md) | [0.2](/filings/0001641172-25-011419.md) | [0.3](/filings/0001641172-25-024455.md) | [0.2](/filings/0001493152-25-023661.md) | [0.1 d](/filings/0001493152-26-014376.md) | [0.0](/filings/0001493152-26-023197.md) | [0.0](/filings/0001641172-25-024455.md) | [0.0](/filings/0001493152-25-023661.md) | [0.0 d](/filings/0001493152-26-014376.md) | not reported | not reported |
| Operating income | $m | [(4.1)](/filings/0001493152-24-045687.md) | [(6.2) d](/filings/0001641172-25-004816.md) | [(3.4)](/filings/0001641172-25-011419.md) | [(5.3)](/filings/0001641172-25-024455.md) | [(3.0)](/filings/0001493152-25-023661.md) | [(1.2) d](/filings/0001493152-26-014376.md) | [(3.0)](/filings/0001493152-26-023197.md) | [(20.4)](/filings/0001493152-26-038293.md) | [(6.1)](/filings/0001493152-25-023661.md) | [(41.6) d](/filings/0001493152-26-014376.md) | [(35.7)](/filings/0001493152-26-023197.md) | [(15.2)](/filings/0001493152-26-038293.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [12.2](/filings/0001493152-26-023197.md) | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(0.8)](/filings/0001493152-25-023661.md) | [(0.5) d](/filings/0001493152-26-014376.md) | [(0.6)](/filings/0001493152-26-023197.md) | [(0.5)](/filings/0001493152-26-038293.md) |
| Net income | $m | [(4.6)](/filings/0001493152-24-045687.md) | [(6.0) d](/filings/0001641172-25-004816.md) | [(3.4)](/filings/0001641172-25-011419.md) | [(3.9)](/filings/0001641172-25-024455.md) | [(1.9)](/filings/0001493152-25-023661.md) | [(1.1) d](/filings/0001493152-26-014376.md) | [(2.8)](/filings/0001493152-26-023197.md) | [(20.4)](/filings/0001493152-26-038293.md) | [(15.6)](/filings/0001493152-25-023661.md) | [(424) d](/filings/0001493152-26-014376.md) | [(46.7)](/filings/0001493152-26-023197.md) | [(14.6)](/filings/0001493152-26-038293.md) |
| Diluted EPS | $ per share | [(0.61)](/filings/0001493152-24-045687.md) | not reported | [(0.36)](/filings/0001641172-25-011419.md) | [(0.30)](/filings/0001641172-25-024455.md) | [(0.12)](/filings/0001493152-25-023661.md) | not reported | [(0.14)](/filings/0001493152-26-023197.md) | [(0.74)](/filings/0001493152-26-038293.md) | [(0.47)](/filings/0001493152-25-023661.md) | not reported | [(0.27)](/filings/0001493152-26-023197.md) | [(0.08)](/filings/0001493152-26-038293.md) |
| Basic EPS | $ per share | [(0.61)](/filings/0001493152-24-045687.md) | not reported | [(0.36)](/filings/0001641172-25-011419.md) | [(0.30)](/filings/0001641172-25-024455.md) | [(0.12)](/filings/0001493152-25-023661.md) | not reported | [(0.14)](/filings/0001493152-26-023197.md) | [(0.74)](/filings/0001493152-26-038293.md) | [(0.47)](/filings/0001493152-25-023661.md) | not reported | [(0.27)](/filings/0001493152-26-023197.md) | [(0.08)](/filings/0001493152-26-038293.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | period not labelled (2026-02-06) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.2](/filings/0001493152-24-014860.md) | [0.4](/filings/0001493152-24-020634.md) | [2.1](/filings/0001493152-24-032374.md) | [0.6](/filings/0001493152-24-045687.md) | [0.1](/filings/0001493152-26-014376.md) | [3.7](/filings/0001641172-25-011419.md) | [2.8](/filings/0001641172-25-024455.md) | [11.0](/filings/0001493152-25-023661.md) | [20.3](/filings/0001493152-26-014376.md) | [38.9](/filings/0001493152-26-038293.md) | [6.9](/filings/0001493152-26-023197.md) | [5.6](/filings/0001493152-26-038293.md) |
| Current assets | $m | [0.5](/filings/0001641172-25-004816.md) | [0.7](/filings/0001493152-24-020634.md) | [2.4](/filings/0001493152-24-032374.md) | [0.8](/filings/0001493152-24-045687.md) | [0.4](/filings/0001493152-26-014376.md) | [4.0](/filings/0001641172-25-011419.md) | [3.0](/filings/0001641172-25-024455.md) | [15.0](/filings/0001493152-25-023661.md) | [71.9](/filings/0001493152-26-038293.md) | not reported | [45.9](/filings/0001493152-26-023197.md) | [34.6](/filings/0001493152-26-038293.md) |
| Total assets | $m | [1.8](/filings/0001641172-25-004816.md) | [1.6](/filings/0001493152-24-020634.md) | [3.1](/filings/0001493152-24-032374.md) | [1.4](/filings/0001493152-24-045687.md) | [0.8](/filings/0001493152-26-014376.md) | [4.4](/filings/0001641172-25-011419.md) | [110](/filings/0001641172-25-024455.md) | [131](/filings/0001493152-25-023661.md) | [188](/filings/0001493152-26-038293.md) | not reported | [173](/filings/0001493152-26-023197.md) | [160](/filings/0001493152-26-038293.md) |
| Current liabilities | $m | [4.6](/filings/0001641172-25-004816.md) | [5.2](/filings/0001493152-24-020634.md) | [3.0](/filings/0001493152-24-032374.md) | [1.7](/filings/0001493152-24-045687.md) | [2.3](/filings/0001493152-26-014376.md) | [1.7](/filings/0001641172-25-011419.md) | [113](/filings/0001641172-25-024455.md) | [126](/filings/0001493152-25-023661.md) | [42.8](/filings/0001493152-26-038293.md) | not reported | [3.3](/filings/0001493152-26-023197.md) | [1.7](/filings/0001493152-26-038293.md) |
| Total liabilities | $m | [4.7](/filings/0001641172-25-004816.md) | [5.8](/filings/0001493152-24-020634.md) | [3.0](/filings/0001493152-24-032374.md) | [1.7](/filings/0001493152-24-045687.md) | [2.3](/filings/0001493152-26-014376.md) | [1.7](/filings/0001641172-25-011419.md) | [113](/filings/0001641172-25-024455.md) | [137](/filings/0001493152-25-023661.md) | [54.2](/filings/0001493152-26-038293.md) | not reported | [14.0](/filings/0001493152-26-023197.md) | [12.4](/filings/0001493152-26-038293.md) |
| Shareholders' equity | $m | [(3.0)](/filings/0001641172-25-004816.md) | [(4.3)](/filings/0001493152-24-020634.md) | [(0.0)](/filings/0001493152-24-032374.md) | [(0.4)](/filings/0001493152-24-045687.md) | [(1.5)](/filings/0001493152-26-014376.md) | [2.6](/filings/0001641172-25-011419.md) | [(3.6)](/filings/0001641172-25-024455.md) | [(7.0)](/filings/0001493152-25-023661.md) | [133](/filings/0001493152-26-038293.md) | not reported | [159](/filings/0001493152-26-023197.md) | [146](/filings/0001493152-26-038293.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.8) d](/filings/0001493152-24-045687.md) | [(2.9) d](/filings/0001641172-25-004816.md) | [(1.3)](/filings/0001641172-25-011419.md) | [(1.5) d](/filings/0001641172-25-024455.md) | [(1.5) d](/filings/0001493152-25-023661.md) | [(0.5) d](/filings/0001493152-26-014376.md) | [(1.1)](/filings/0001493152-26-023197.md) | [(1.3) d](/filings/0001493152-26-038293.md) | [(5.0) d](/filings/0001493152-25-023661.md) | [(3.0) d](/filings/0001493152-26-014376.md) | [(10.2)](/filings/0001493152-26-023197.md) | [(11.7) d](/filings/0001493152-26-038293.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001493152-24-045687.md) | [0.0 d](/filings/0001641172-25-004816.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.0](/filings/0001493152-23-041256.md) | [6.2](/filings/0001493152-24-020634.md) | [7.0](/filings/0001493152-24-032374.md) | [7.5](/filings/0001493152-24-045687.md) | [9.9](/filings/0001641172-25-011419.md) | [12.9](/filings/0001641172-25-024455.md) | [16.2](/filings/0001493152-25-023661.md) | [20.8](/filings/0001493152-26-023197.md) | [27.7](/filings/0001493152-26-038293.md) | [33.4](/filings/0001493152-25-023661.md) | [175](/filings/0001493152-26-023197.md) | [182](/filings/0001493152-26-038293.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 116,465,417 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038293.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.